Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph B Olivier

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Circulation. Cardiovascular Interventions|May 30, 2025
Aspirin in Dual Antiplatelet Therapy After PCI: One Duration Does Not Fit AllUwe Zeymer, Christoph B Olivier, Daniel Dürschmied
European Heart Journal|September 11, 2019
Anticoagulation and anaemia: old opponents from the era of VKA?Christoph Bode, Christoph B Olivier, Daniel Duerschmied
Journal of the American College of Cardiology|September 21, 2019
Is Bleeding Always Bad?: Bad Boy BleedingChristoph Bode, Christoph B Olivier, Daniel Duerschmied
European Heart Journal|December 5, 2013
Triple antithrombotic therapy in cardiac patients: more questions than answersMartin Moser, Christoph B Olivier, Christoph Bode
Expert Opinion on Drug Safety|January 25, 2018
Anticoagulant and antiplatelet therapy choices for patients with atrial fibrillation one year after coronary stenting or acute coronary syndromeChristoph B Olivier, Mintu P Turakhia, Kenneth W Mahaffey
European Heart Journal Open|July 10, 2023
Comparison of phenprocoumon with direct oral anticoagulants in catheter ablation of atrial fibrillationDiona Gjermeni, Nertila Poci Saglam, Christoph B Olivier, et al.
Journal of Thrombosis and Thrombolysis|February 4, 2016
Platelet reactivity after administration of third generation P2Y12-antagonists does not depend on body weight in contrast to clopidogrelChristoph B Olivier, Katharina Schnabel, Susanne Weber, et al.
Thrombosis and Haemostasis|November 1, 2013
Third generation P2Y12 antagonists inhibit platelet aggregation more effectively than clopidogrel in a myocardial infarction registryChristoph B Olivier, Philipp Diehl, Katharina Schnabel, et al.
The Journal of Cardiovascular Surgery|March 14, 2018
Moderate ischemic mitral regurgitation: coronary artery bypass grafting with versus without simultaneous treatment of the mitral valveJonathan Rilinger, Claudia Heilmann, Ulrich Beitinger, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|July 28, 2025
Comparing the efficacy and safety of direct oral anticoagulants with vitamin K antagonists in dialysis patients with nonvalvular atrial fibrillation: a systematic review and meta-analysisTian Li, Tong Li, Yujun Xu, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Circulation. Cardiovascular Interventions|May 30, 2025
Aspirin in Dual Antiplatelet Therapy After PCI: One Duration Does Not Fit AllUwe Zeymer, Christoph B Olivier, Daniel Dürschmied
European Heart Journal|September 11, 2019
Anticoagulation and anaemia: old opponents from the era of VKA?Christoph Bode, Christoph B Olivier, Daniel Duerschmied
Journal of the American College of Cardiology|September 21, 2019
Is Bleeding Always Bad?: Bad Boy BleedingChristoph Bode, Christoph B Olivier, Daniel Duerschmied
European Heart Journal|December 5, 2013
Triple antithrombotic therapy in cardiac patients: more questions than answersMartin Moser, Christoph B Olivier, Christoph Bode
Expert Opinion on Drug Safety|January 25, 2018
Anticoagulant and antiplatelet therapy choices for patients with atrial fibrillation one year after coronary stenting or acute coronary syndromeChristoph B Olivier, Mintu P Turakhia, Kenneth W Mahaffey
European Heart Journal Open|July 10, 2023
Comparison of phenprocoumon with direct oral anticoagulants in catheter ablation of atrial fibrillationDiona Gjermeni, Nertila Poci Saglam, Christoph B Olivier, et al.
Journal of Thrombosis and Thrombolysis|February 4, 2016
Platelet reactivity after administration of third generation P2Y12-antagonists does not depend on body weight in contrast to clopidogrelChristoph B Olivier, Katharina Schnabel, Susanne Weber, et al.
Thrombosis and Haemostasis|November 1, 2013
Third generation P2Y12 antagonists inhibit platelet aggregation more effectively than clopidogrel in a myocardial infarction registryChristoph B Olivier, Philipp Diehl, Katharina Schnabel, et al.
The Journal of Cardiovascular Surgery|March 14, 2018
Moderate ischemic mitral regurgitation: coronary artery bypass grafting with versus without simultaneous treatment of the mitral valveJonathan Rilinger, Claudia Heilmann, Ulrich Beitinger, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|July 28, 2025
Comparing the efficacy and safety of direct oral anticoagulants with vitamin K antagonists in dialysis patients with nonvalvular atrial fibrillation: a systematic review and meta-analysisTian Li, Tong Li, Yujun Xu, et al.
Pageof 5